AI-powered digital pathology is redefining modern cancer care by extending clinical-grade insights beyond the microscope and enabling standardized, pixel-level analysis to support scalable cancer diagnostics anytime, anywhere.
Reliable tumor content analysis for colorectal carcinoma specimens.
HALO Macrodissection Solutions Read More »
Reliable tumor content analysis for colorectal carcinoma specimens.
CRC Macrodissect AI Read More »
Reliable tumor content analysis for non-small cell lung cancer specimens.
Lung Macrodissect AI Read More »
AI-powered tools that quantify tumor content and guide ROI selection to enhance macrodissection workflows and downstream molecular analysis.
HALO Macrodissection Solutions – Read More »
An automated, AI-based decision-support tool that standardizes scoring of HER2, ER, PR, and Ki67 IHC in breast cancer cases.
An automated, AI-based decision-support tool that standardizes the scoring of PD-L1 IHC in NSCLC cases.
An automated, AI-based tool for quality control of whole slide H&E- and IHC-stained images.
30 November 2023 | Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer
